Every News Matters
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) with the stream of -2.17% in the last hour of trading session. FDA Approves Aurinia Pharmaceuticals’ LUPKYNIS (voclosporin) for Adult Patients with Active Lupus Nephritis Aurinia …
Read More
Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) reached at $13.83 price level during last trade its distance from 20 days simple moving average was -3.23%, and its distance from 50 days …
Read More
On Friday, shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) reached at $13.83 price level during last trade its distance from 20 days simple moving average was -3.23%, and its distance from …
Read More
On Thursday, shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) reached at $13.83 price level during last trade its distance from 20 days simple moving average was -3.23%, and its distance from …
Read More
On Wednesday, shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) reached at $13.94 price level during last trade its distance from 20 days simple moving average was -2.67%, and its distance from …
Read More